Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€96.28

€96.28

0.230%
0.22
0.230%
-
 
15.04.24 / Tradegate WKN: 850943 / Symbol: PKI / Name: PerkinElmer / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

PerkinElmer Inc. Stock

PerkinElmer Inc. gained 0.230% compared to yesterday.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for PerkinElmer Inc. stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of PerkinElmer Inc. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of PerkinElmer Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
PerkinElmer Inc. 0.230% -1.775% -0.062% -22.822% -3.864% -14.342% 7.853%
QuidelOrtho Corp. -3.080% -1.015% -12.142% -54.461% -42.495% -62.892% -
Boston Scientific 1.570% 0.000% 4.441% 34.877% 23.445% 86.053% 89.552%
Illumina Inc. -2.530% -4.904% -2.663% -45.011% -11.268% -66.025% -61.395%

Comments

Sell PerkinElmer Inc.
Show more

Buy PerkinElmer Inc.
Show more

News

Why Revvity Stock Plunged Today: https://g.foolcdn.com/editorial/images/752972/woman-lab-science-research-stem.jpg
Why Revvity Stock Plunged Today

Shares of Revvity (NYSE: RVTY) -- formerly known as PerkinElmer -- fell 16.1% on Monday after the health science solutions and services company announced weaker-than-expected third-quarter 2023